Journal News

JLR: Finding the structure of a lipid that keeps our tears clear

Laurel Oldach
September 01, 2018

Because humans evolved from the sea, we carry a little of it with us to stay alive. Salt water makes up the cytoplasm in our cells, the plasma in our blood and the tears in our eyes.

This image by first author Sarah Hancock shows an iris surrounded by the lipid she and colleagues in the Blanksby and Mitchell labs characterized by mass spectronomy.Journal of Lipid Research

But water alone isn’t enough to keep the eye from drying out. A microscopically thin film of oils known as the lipid layer protects the tear film from evaporating. In the August issue of the Journal of Lipid Research, a group of Australian researchers reports the structure of a key long-chain lipid in this layer. Their finding may be used to improve treatments for dry eye.

Although the long-chain lipids in question make up just 5 percent of the tear-film lipid layer, they play an important role in vision. Without them, earlier studies showed, the lipid layer would resemble an oil slick atop a puddle.

“This clearly wouldn’t be satisfactory for you to look through,” said Stephen Blanksby, a professor at the Queensland University of Technology who led the research team in this study.

Blanksby saw the earlier research in Langmuir troughs carried out by others as a prompt to determine the precise structure of the ultra-long-chain lipids of the eye.

The tear-film lipid layer comes from meibum secreted by the lower eyelid. Scientists can collect meibum samples from brave volunteers by running a small spatula gently over their lower lids, but it is difficult to obtain enough for conventional assays like nuclear magnetic resonance spectroscopy.

Complicating matters, the team needed to differentiate between isomers. They knew the long lipids were made of two fatty acids but not whether they were joined end-to-end or branched, a question conventional mass spectrometry couldn’t answer.

Fortunately, Blanksby and colleague Todd Mitchell of the University of Wollongong have spent the last decade fine-tuning mass spectrometric techniques to characterize lipids.

“We were able to bring a unique toolbox to bear,” said Blanksby. “Some of these techniques may not exist outside Todd’s and my laboratory.”

By incorporating established approaches, such as ozonolysis, into a mass spectrometry workflow, the team determined that the most abundant of the ultra-long lipids is joined end-to-end, and they pinpointed each of its double bonds. The mass spectrometrists handed off the structure to chemist colleagues led by Michael Kelso, who developed a method to synthesize it.

The team now is working with industry partner Allergan, which cofunded the research with the Australian Research Council, on incorporating the new synthetic long-chain lipid as a component of drops for dry eye. While our knowledge of the lipid layer has expanded, according to Blanksby many eye drops still use mineral oil.

“This type of work provides a framework to produce a product that mimics, and is based on, the actual components that are present in human tears,” he said.

Blanksby hopes that by creating a better match to the real tear film, blurriness and other side effects of using eye drops can be alleviated.

Laurel Oldach

Laurel Oldach is a science writer for the ASBMB.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in Science

Science highlights or most popular articles

Stopping the devil in the dust
Feature

Stopping the devil in the dust

April 07, 2020

As clinicians, veterinarians and research scientists close in on potential vaccines for the devastating fungal illness Valley fever, the largest barrier likely remains outside the lab.

Life's little oscillations
News

Life's little oscillations

April 05, 2020

Concentrations of molecules rise and fall, genes switch on and off, and circadian clocks keep time. These biochemical fluctuations are crucial for myriad biological needs, and cells couldn't function without them.

A small trial finds that hydroxychloroquine is not effective for treating coronavirus
News

A small trial finds that hydroxychloroquine is not effective for treating coronavirus

April 05, 2020

Despite the recent approval of this drug for use against COVID-19, questions remain as to the efficacy of this treatment.

Team Cryo ices Mass Spec’s hopes in JBC Methods Madness tourney
Journal News

Team Cryo ices Mass Spec’s hopes in JBC Methods Madness tourney

April 03, 2020

In the inaugural JBC Methods Madness Tournament, cryo­–EM/ET gave structural biologists around the world something to cheer about, beating mass spectrometry 51% to 49% —​ a margin thinner than shaved ice. 

A small army of researchers races to build a coronavirus interactome
News

A small army of researchers races to build a coronavirus interactome

April 01, 2020

Scientists at eight institutions in the U.S. and Europe have used a protein interaction map to identify 69 drugs that might work against SARS-CoV-2, the virus that causes COVID-19.

Parkinson's  Awareness Month
Health Observance

Parkinson's Awareness Month

April 01, 2020

It is the second-most common progressive neurodegenerative disease, occurring in 1% of people over the age of 60 and in 5% of people over 85.